نتایج جستجو برای: s lymphoma nhl

تعداد نتایج: 809197  

2014
Unhee Lim Jonathan M. Kocarnik William S. Bush Tara C. Matise Christian Caberto Sungshim Lani Park Christopher S. Carlson Ewa Deelman David Duggan Megan Fesinmeyer Christopher A. Haiman Brian E. Henderson Lucia A. Hindorff Laurence N. Kolonel Ulrike Peters Daniel O. Stram Maarit Tiirikainen Lynne R. Wilkens Chunyuan Wu Charles Kooperberg Loïc Le Marchand

BACKGROUND Risk of non-Hodgkin lymphoma (NHL) is higher among individuals with a family history or a prior diagnosis of other cancers. Genome-wide association studies (GWAS) have suggested that some genetic susceptibility variants are associated with multiple complex traits (pleiotropy). OBJECTIVE We investigated whether common risk variants identified in cancer GWAS may also increase the ris...

Journal: :Leukemia research 1991
L M Pottern M Linet A Blair F Dick L F Burmeister R Gibson L M Schuman J F Fraumeni

To investigate whether a history of hematolymphoproliferative cancers (HLP) and other cancers among a parent or sibling is a risk factor for specific subtypes of leukemia and non-Hodgkin's lymphoma (NHL), data from a population-based case-control study, in Iowa and Minnesota, of 578 leukemia cases, 622 NHL cases and 1245 controls were evaluated. Having at least one sibling with HLP significantl...

2014
Marko Erak Milana Mitric

Lymphoma of the orbit is a rare presentation of nonHodgkin’s lymphoma (NHL). According to the data from the literature, orbital lymphoma represents 8% of all extranodal NHL and about 1% of all NHL [1-3]. Symptoms which are usually caused by orbital lymphoma are proptosis, periorbital swelling, conjunctival (salmonpink) swelling, diplopia, and conjunctival redness and irritation [4]. Radiotherap...

NHL is the most common hematologic cancer in adults. Rituximab is the FDA approved treatment of relapsed or refractory low grade B-cell Non-Hodgkin Lymphoma (NHL). But patients eventually become resistant to rituximab. Since lymphocytes and lymphoma cells are highly radiosensitive, low grade NHL that has relapsed or refractory to standard therapy is treated by RIT in which a beta-emitting radio...

2011
L. Lee L. Wang M. Crump

BACKGROUND The correlation between efficacy end points in randomized controlled trials (RCTs) of systemic therapy for non-Hodgkin's lymphoma (NHL) was investigated to identify an appropriate surrogate end point for overall survival (OS). METHODS RCTs of previously untreated NHL published from 1990 to 2009 were identified. Associations between absolute differences in efficacy end points were d...

Journal: :Clinical journal of oncology nursing 2013
Elizabeth Sorensen

Indolent lymphoma is one of the most frequently occurring subtypes of non-Hodgkin lymphoma (NHL). Indolent NHL has a long natural history, and patients will likely receive multiple therapies during the course of their disease. Treatment options are rapidly evolving and, because oncology nurses play a major role in managing patients undergoing treatment for indolent NHL, they need to be aware of...

2013
Noor-i-kiran Naeem Farhatulain Ahmed Shamila Yasir

Non-Hodgkin lymphoma (NHL) causes many deaths worldwide with increasing incidence. Non-Hodgkin's lymphoma (NHL) may involve the gynecologic tract, and the ovary to be one of the commoner anatomic sites as reported. Ovarian involvement by NHL is usually secondary, occurring as a part of systemic disease. The diagnosis is often made incidentally while investigating for gynecological symptoms. We ...

Journal: :World journal of pediatrics : WJP 2011
Marie Therese Manipadam Sheila Nair Auro Viswabandya Leni Mathew Alok Srivastava Mammen Chandy

BACKGROUND There is a dearth of published literature on the frequency and distribution of pediatric and adolescent non-Hodgkin lymphoma (NHL) in India according to the 2001 WHO classification. The aim of this study was to record the distribution of the different subtypes, analyze the major subtypes, and compare it with the published data from other countries. A review of pediatric NHL statistic...

2015
Ali Shahriari-Ahmadi Babak Izadi Masoud Sadeghi Mehrdad Payandeh Edris Sadeghi

Background: Epstein-Barr virus (EBV) infection is highly associated with specific subtypes of malignant lymphoma such as types of aggressive non-Hodgkin lymphoma (NHL). We aimed to evaluate the prevalence of EBV in NHL and its association with clinical parameters. Patients and Methods: twenty cases entered to our study. After re-blocking of previous paraffin embedded specimens, new slides were ...

Journal: :Blood 2012
Javier A Laurini Anamarija M Perry Eugene Boilesen Jacques Diebold Kenneth A Maclennan H Konrad Müller-Hermelink Bharat N Nathwani James O Armitage Dennis D Weisenburger

The distribution of non-Hodgkin lymphoma (NHL) subtypes differs around the world but a systematic study of Latin America has not been done. Therefore, we evaluated the relative frequencies of NHL subtypes in Central and South America (CSA). Five expert hematopathologists classified consecutive cases of NHL from 5 CSA countries using the WHO classification and compared them to 400 cases from Nor...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید